United States · FDA National Drug Code directory
Lurasidone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-495_2ad2918d-7142-4425-bd00-45a269ef0d61
- Product NDC
- 62332-495
- Form
- TABLET, FILM COATED
- Composition / generic term
- Lurasidone Hydrochloride
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230124
- Source listing expiry
- 20261231
Source-listed ingredients
- LURASIDONE HYDROCHLORIDE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 BLISTER PACK in 1 CARTON (62332-495-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 62332-495-10
- 30 TABLET, FILM COATED in 1 BOTTLE (62332-495-30) · 62332-495-30
- 500 TABLET, FILM COATED in 1 BOTTLE (62332-495-71) · 62332-495-71
- 90 TABLET, FILM COATED in 1 BOTTLE (62332-495-90) · 62332-495-90
- 1000 TABLET, FILM COATED in 1 BOTTLE (62332-495-91) · 62332-495-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →